Hong Kong General Merchandise and Department Stores Stock News

HSBC’s latest Asia emerging markets report has put China Resources Land (SEHK:1109) on investors’ radar after highlighting expected margin improvement and upcoming flagship launches in Shanghai and Shenzhen. See our latest analysis for China Resources Land. At a share price of HK$37.28, China Resources Land has seen short term momentum cool slightly with a 1 month share price return that declined 2.41%. However, the 90 day share price return of 23.94% and 1 year total shareholder return of...

Chow Tai Fook Jewellery Group (SEHK:1929) just posted its FY 2026 results with second half revenue of HK$55.4b and basic EPS of HK$0.66, capping a year in which earnings grew 52.2% and net margin reached 9.5%. Over the past few reporting periods, revenue has moved from HK$50.2b in 2H FY 2025 to HK$38.0b in 1H FY 2026 and then to HK$55.4b in 2H FY 2026, while basic EPS shifted from HK$0.34 to HK$0.26 and then to HK$0.66. This progression gives investors a clearer view of how profitability is...

Fresh from releasing its FY 2026 numbers, Eagle Nice (International) Holdings (SEHK:2368) reported first half revenue of HK$3.3 billion and basic EPS of HK$0.36, with trailing twelve month revenue at HK$5.1 billion and basic EPS at HK$0.30. Over the past three reported half year periods, revenue has moved from HK$3.0 billion in 1H FY 2025 to HK$1.8 billion in 2H FY 2025 and HK$3.3 billion in 1H FY 2026, while basic EPS shifted from HK$0.33 to HK$0.06 and then HK$0.36, setting up a mixed...

In June, Everest Medicines (SEHK:1952) signed a global out licensing deal with Travere Therapeutics for its BTK inhibitor civorebrutinib (EVER001). The company also agreed to acquire presbyopia therapy LNZ100 from Corxel Pharmaceuticals and secured a regional cardiovascular licensing partnership for Sumecigrel from Jiangsu Vcare PharmaTech. Together, these transactions expand Everest Medicines' pipeline in nephrology, ophthalmology and cardiovascular disease while widening its collaboration...

Event overview and immediate market reaction LongBio Pharma (Suzhou) (SEHK:1779) moved higher in the latest session, with the stock closing at HK$141.9 after a 3.2% gain for the day, drawing fresh attention from biotech focused investors. See our latest analysis for LongBio Pharma (Suzhou). The 3.2% one day share price return fits into a year to date share price return of 7.66%. This suggests momentum has been gradually building as investors reassess LongBio Pharma (Suzhou)'s risk and growth...

Dividend approval and board changes put Wanguo Gold Group (SEHK:3939) in focus Wanguo Gold Group (SEHK:3939) has drawn fresh attention after shareholders approved a final dividend of RMB 10.10 cents, or HK$0.112 per share, at the 5 June 2026 annual general meeting. The AGM also confirmed governance changes, with executive director Mr. Liu Zhichun retiring and executive director Ms. Gao Jinzhu joining the remuneration committee. This provides investors with new information on both capital...

As global markets navigate a complex landscape marked by technology sector volatility and economic resilience, Asia's tech industry continues to capture investor attention with its potential for high growth amidst uneven economic recoveries. In this environment, identifying strong stocks often involves looking for companies that demonstrate robust innovation capabilities and adaptability to shifting market dynamics, particularly in sectors like artificial intelligence where commercialization...

Regulatory filing for extended-range EV sparks fresh focus on Xiaomi stock Xiaomi (SEHK:1810) has filed to add an extended-range electric vehicle to its lineup, broadening its SU7 sedan and YU7 SUV offering and giving investors another reference point for assessing the company’s smart EV segment. See our latest analysis for Xiaomi. The latest regulatory filing lands against a weaker backdrop for the stock, with the 30 day share price return down 17.86% and the year to date share price return...

Art Group Holdings (SEHK:565) has called an extraordinary general meeting for July 2026 to seek shareholder approval to renew its mandate to issue up to 20% new shares. See our latest analysis for Art Group Holdings. At a share price of HK$3.06, Art Group Holdings has seen strong momentum build recently, with a 30 day share price return of 4.79% and a year to date share price return of 120.14%. The 1 year total shareholder return of 197.09% and very large 3 year total shareholder return...

Earnings and Analyst Sentiment Put Kingboard Laminates Holdings (SEHK:1888) in Focus Kingboard Laminates Holdings (SEHK:1888) is back on investors’ radar after its latest earnings report showed improved quarterly revenue and net profit versus a year earlier, alongside continued supportive views from major banks. See our latest analysis for Kingboard Laminates Holdings. The latest move has come on top of rapid momentum, with the share price up 9.8% in the last session and a 30 day share price...

Dividend approval puts China Resources Building Materials Technology Holdings in focus China Resources Building Materials Technology Holdings (SEHK:1313) has approved a final ordinary dividend of HK$0.024 per share for the 2025 financial year. Shareholders are set to receive payment on 22 July 2026. See our latest analysis for China Resources Building Materials Technology Holdings. The dividend decision comes after a weak run for the stock, with the share price down 14.89% over the past month...

Bond sale puts Tencent’s AI funding plans in focus Tencent Holdings (SEHK:700) is marketing a dual currency bond offering that could raise up to US$4.5b, its first dollar bond since 2021. The proceeds are earmarked for refinancing, general corporate needs, and AI development. See our latest analysis for Tencent Holdings. Despite Tencent’s fresh bond plans and AI announcements, the stock has been weak in the short term, with the share price down 16.5% over three months and the 1-year total...

China Zheshang Bank (SEHK:2016) has introduced a new governance setup after receiving National Financial Regulatory Administration approval to amend its Articles of Association, removing the Board of Supervisors and assigning its powers to the Audit Committee. See our latest analysis for China Zheshang Bank. These governance changes come shortly after the approval of a final cash dividend and arrive at a time when the share price, at HK$2.54, shows limited short term movement. The three year...

People's Insurance Company (Group) of China (SEHK:1339) has been thrust into focus after chairperson Ms. Ding Xiangqun resigned due to a job transfer. She is stepping down from several key board and committee roles. See our latest analysis for People's Insurance Company (Group) of China. The leadership change lands against a mixed backdrop, with the current share price at HK$5.26, a 7 day share price return of 3.95% and a year to date share price return down 24.86%. At the same time, the 5...

Texwinca Holdings (SEHK:321) has just reported FY 2026 first half revenue of HK$2.7b and basic EPS of HK$0.08, with trailing twelve month EPS at HK$0.12 and revenue at HK$5.1b setting the overall earnings backdrop. Over recent halves the company has seen revenue move from HK$3.0b and EPS of HK$0.07 in 1H FY 2025 to HK$2.6b and EPS of HK$0.01 in 2H FY 2025, before landing at the latest HK$2.7b and HK$0.08 print. This feeds into trailing earnings growth of 38.4% and a 3.1% net margin. For...

Recent share performance and business snapshot JF SmartInvest Holdings (SEHK:9636) has drawn attention after a sharp pullback, with the stock down 33% over the past month and 23% over the past 3 months, prompting closer scrutiny of its fundamentals. The company operates as an online financial information provider in the People’s Republic of China, offering market data processing, investment decision support tools, cloud charting, investor education content, and livestreamed market commentary...

Kingsoft (SEHK:3888) has cut its final dividend to HK$0.13 per share for 2025, while also approving a new Memorandum and Articles at its 28 May 2026 annual general meeting, reshaping its shareholder framework. See our latest analysis for Kingsoft. Despite the dividend cut and refreshed governance framework, the share price has been volatile. The 7 day share price return is 9.30%, but the year to date share price return is down 16.24%, while the 1 year total shareholder return has fallen...

J&T Global Express (SEHK:1519) has just been added to the Hang Seng Index, drawing fresh attention to the stock as index-tracking investors reassess its role in Hong Kong portfolios. See our latest analysis for J&T Global Express. Despite the Hang Seng inclusion and the recent private placement involving SF Holdings Group, the stock has been weak in recent months, with a 30 day share price return down 8.25% and year to date share price return down 15.56%. However, the 1 year total shareholder...

As global markets navigate a complex landscape of economic indicators and geopolitical tensions, investors are increasingly turning their attention to the opportunities within Asian equities. Penny stocks, despite their somewhat antiquated name, continue to attract interest due to their potential for significant value appreciation. By focusing on companies with strong financial foundations and growth potential, investors can uncover promising opportunities among these smaller or newer market...

As global markets experience volatility, with mixed performances across major indices and economic data highlighting resilience amidst inflationary pressures, investors are increasingly looking towards Asia for opportunities in dividend stocks. In such an environment, a good dividend stock is often characterized by its ability to provide consistent returns through stable payouts, even as broader market conditions fluctuate.

At its annual general meeting on May 29, 2026, Xinyi Solar Holdings Limited obtained shareholder approval to declare and pay a final dividend of HK$0.008 per share for the year ended December 31, 2025. This dividend decision highlights how the company is choosing to return cash to shareholders while signaling its current capital allocation priorities. We will now examine how the approved final dividend shapes Xinyi Solar Holdings' investment narrative and what it may imply for investors. The...

In early June 2026, Innovent Biologics presented new clinical and preclinical data across its obesity and metabolic pipeline at the American Diabetes Association Scientific Sessions, including first-in-human results for its oral GLP-1 receptor agonist IBI3032 and updates on mazdutide and other next-generation candidates. A distinctive angle for investors is Innovent’s push into true oral and once-weekly small-molecule GLP-1 therapies, aiming to combine low-dose efficacy with improved...

China Communications Services (SEHK:552) is back in focus after shareholders approved a final dividend and a broad share issuance mandate at the recent Annual General Meeting, alongside an executive reshuffle in senior management. See our latest analysis for China Communications Services. Despite the recent AGM approvals and executive changes, the share price is at HK$4.33 after a 5.35% 1 day share price return. The 1 year total shareholder return of 5.04% reflects steadier long term gains,...

Insiders who bought CN¥17.0m worth of Starjoy Wellness and Travel Company Limited ( HKG:3662 ) stock in the last year...